According to a national study conducted in the United Kingdom, the Oxford-AstraZeneca vaccine, known in India as Covishield, may have a very low risk of developing...
An alternative vaccine should be offered to people under the age of 30 in the UK for AstraZeneca jab for evidence linking it to rare blood...
Recent Comments